Does Taking Mounjaro Make You Cold?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, can trigger sensations of coldness or temperature sensitivity in certain patients. This side effect is not dangerous but relates to how the medication affects your body's metabolic rate and thermoregulation during weight loss.

Why Tirzepatide May Cause Chills and Cold Sensitivity

When tirzepatide slows your metabolism and reduces appetite, your body burns fewer calories at rest. This decrease in metabolic activity can lower your core body temperature slightly, making you feel colder than usual, especially in cool environments. The sensation typically emerges within the first few weeks of treatment as your system adapts to the medication's effects on your GLP-1 and GIP pathways.

Rapid weight loss itself contributes to temperature sensitivity because fat tissue provides insulation. As you lose weight faster on tirzepatide, your body loses some of that thermal protection, and you may experience increased cold sensations. This is a temporary adjustment that often stabilizes once your weight reaches a new baseline.

How Cold Sensitivity Differs From Dangerous Side Effects

Feeling cold while on tirzepatide is generally harmless and distinct from serious adverse reactions like pancreatitis or thyroid issues. Temperature sensitivity typically resolves on its own within 4–8 weeks as your body acclimates to the medication. Unlike nausea or injection site reactions, chills do not require medication changes or medical intervention in most cases.

PlexusDx patients can manage cold sensitivity by wearing layers, adjusting room temperature, or increasing warm beverage intake. These practical measures address comfort without interrupting your weight loss progress. If coldness is severe or accompanied by fever, unexplained fatigue, or muscle pain, notify your PlexusDx care team immediately.

Metabolic Changes Behind Temperature Regulation on GLP-1 Therapy

Tirzepatide activates GLP-1 and GIP receptors in your brain's hypothalamus, the region controlling hunger, satiety, and thermoregulation. This dual activation suppresses appetite and alters how your body distributes energy, often resulting in a modest reduction in resting metabolic rate. The hypothalamus interprets these signals as a need to conserve energy, triggering the sensation of coldness.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, and FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Managing Cold Symptoms While Using Tirzepatide

Stay proactive about temperature comfort by dressing in thermal layers and keeping a blanket accessible during work or leisure time. Warm foods and beverages like broth, herbal tea, and soups not only address cold sensitivity but also support hydration during GLP-1 therapy. Monitor your symptoms daily and note when chills occur—morning, evening, or in specific settings—to identify patterns.

PlexusDx's tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) flat, with no flat per-compound pricing increases as your therapy advances. If cold sensitivity persists beyond 8 weeks or worsens, your PlexusDx clinician may adjust your injection frequency or explore alternative compounds like semaglutide, which affects thermoregulation differently. The Precision Peptide Genetic Test ($99 add-on after your first month) can reveal whether your genetic predispositions make you more susceptible to metabolic side effects, enabling truly personalized adjustments.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is feeling cold on tirzepatide a sign something is wrong?

No. Cold sensitivity is a common, temporary metabolic adjustment during tirzepatide therapy and typically resolves within weeks. However, if chills are accompanied by fever, chest pain, or severe fatigue, contact your PlexusDx care team right away to rule out other conditions.

How long does tirzepatide-related coldness last?

Most patients notice temperature sensitivity peaks during weeks 2–4 of treatment and improves significantly by week 6–8. Individual timelines vary based on your genetic metabolism and how quickly your body adapts to the medication's GLP-1 and GIP receptor activation.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The Precision Peptide Genetic Test analyzes your GLP1R, GIPR, FTO, and MC4R variants to forecast your metabolic response and likelihood of temperature sensitivity. This $99 add-on after your first month enables your PlexusDx provider to tailor tirzepatide dosing and timing to minimize discomfort.

What's the cost of tirzepatide at PlexusDx?

PlexusDx's compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) flat across all commitment tiers—your dose may need to go up, but your price won't. No insurance, membership fee, or HSA/FSA requirement applies, and service covers all 50 states.

Should I stop tirzepatide if I feel too cold?

Do not stop treatment without speaking to your PlexusDx clinician first. Cold sensitivity alone is not a reason to discontinue therapy. Your provider may adjust your injection schedule, switch you to oral tirzepatide, or recommend a different compound like semaglutide to improve tolerability while maintaining weight loss benefits.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.